News: American Society of Clinical Oncology

New Cancer Drug Shows Promise

Thursday, July 12th, 2012

An experimental drug that activates T-cells and promotes an immune response to fight tumors has shown promising early results in patients with kidney cancer, melanoma and non-small cell lung cancer. Vanderbilt-Ingram Cancer Center investigators Leora Horn, M.D., Jeffrey Sosman, M.D., and researchers from several other cancer centers tested the new compound. The results of the […]

Lovly Lands Young Investigator Award

Friday, April 22nd, 2011

Christine Lovly, M.D., Ph.D., a fellow in the Division of Hematology/Oncology at Vanderbilt-Ingram Cancer Center (VICC), has been selected to receive a 2011 Young Investigator Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO). The $50,000 grant will help fund Lovly’s research on the molecular mechanisms that alter the effectiveness […]